Clinical Trial

PSMA-Targeted Intraoperative Fluorescent Imaging Agents (DGPR1008): Validation Across Different Time Windows

Study acronym: DGPR1008-04
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 4, 2026 (before its estimated July 27, 2026 completion). Its status may not reflect the trial's current state.
Summary
a Phase II, single-arm, open-label, multi-center study to evaluate safety, tolerability, pharmacokinetics, and the effectiveness of near-infrared fluorescence imaging during surgery.
Trial Details
NCT Number NCT07387510
Lead Sponsor Haitao Niu, MD
Conditions Prostate Cancer Patients Undergoing Radical Prostatectomy
Enrollment 27 participants
Start Date 2026-02-27
Primary Completion 2026-07-27 (estimated)
Study Completion 2026-09-27 (estimated)
Updated on ClinicalTrials.gov 2026-02-04